好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Targeted versus High-Intensity Monitoring Following Intravenous Thrombolysis in Acute Ischemic Stroke
Cerebrovascular Disease and Interventional Neurology
P4 - Poster Session 4 (5:00 PM-6:00 PM)
13-016
We studied a targeted-intensity monitoring (TIM) protocol for low-risk acute ischemic stroke (AIS) patients following IVT.
Conventional high-intensity monitoring (HIM) post-intravenous thrombolysis (IVT) is resource-intensive and of unclear utility in low-risk AIS patients.

Low-risk post-IVT AIS patients (NIHSS≤10, BP<180/105, no high-risk stenosis/occlusion, preserved level of consciousness) between 10/2020-4/2024 were included. The HIM protocol was utilized in the ICU until March 2022, thereafter TIM was utilized in the intermediate care unit (IMC). HIM protocol vital sign monitoring and neurochecks occurred q15 minutes for 2 hours, q30 minutes for 6 hours, then q1 hour for 16 hours (72 total assessments); TIM protocol vital sign monitoring and neurochecks occurred q15 minutes for one hour, q1 hour for three hours, q2 hours for 8 hours, then q4 hours for 12 hours (28 total assessments). We examined the frequency TIM patients were transferred to the ICU, ICU length of stay, hospital length of stay, symptomatic intracranial hemorrhage (sICH), and early neurologic deterioration (END [NIHSS increase ≥4]). Statistical testing was performed using chi-squared tests and two sample t-test. 


95 patients were included: 47 HIM (median age 71 [IQR 56-75.5], median NIHSS 4) and 48 TIM (median age 65, [IQR 60-81.25], median NIHSS 4). The mean ICU stay for HIM  was 32.8 hours; no TIM patients were transferred from IMC to ICU. There was no difference in sICH: HIM 2.1% vs. TIM 0% (p=0.31); median hospital length of stay: HIM 49.8 hours (IQR: 43.8-83.3) vs TIM 49.6 hours (IQR: 32.6-99.7) (p=0.716), END: HIM 0% vs TIM: 2.1% (p=0.320). 

A post-IVT TIM protocol was feasible and safe in selected post-IVT AIS patients. TIM protocols may conserve healthcare resources and increase ICU bed availability. 


Authors/Disclosures
Sohum Bindra
PRESENTER
Mr. Bindra has nothing to disclose.
Carl-Lewis Valcinord, MD Dr. Valcinord has nothing to disclose.
Jodi Mueller (Community Health Network) No disclosure on file
Marcus Milani Mr. Milani has nothing to disclose.
Megan Tessmer, RN Mrs. Tessmer has nothing to disclose.
Christopher Streib, MD (Department of Neurology) Dr. Streib has nothing to disclose.
Abbey Staugaitis Abbey Staugaitis has nothing to disclose.